2012 Consensus Document of the Italian Society of Hypertension (SIIA): Strategies to Improve Blood Pressure Control in I
- PDF / 273,228 Bytes
- 8 Pages / 595.276 x 790.866 pts Page_size
- 52 Downloads / 160 Views
CONSENSUS DOCUMENT
2012 Consensus Document of the Italian Society of Hypertension (SIIA): Strategies to Improve Blood Pressure Control in Italy From Global Cardiovascular Risk Stratification to Combination Therapy Massimo Volpe • Enrico Agabiti Rosei • Ettore Ambrosioni • Santina Cottone • Cesare Cuspidi • Claudio Borghi • Nicola De Luca • Francesco Fallo • Claudio Ferri • Alberto Morganti • Maria Lorenza Muiesan • Riccardo Sarzani • Leonardo Sechi • Agostino Virdis • Giuliano Tocci • Bruno Trimarco • Alessandro Filippi • Giuseppe Mancia Received: 8 October 2012 / Accepted: 12 October 2012 / Published online: 28 March 2013 Ó Springer International Publishing Switzerland 2013
Abstract Observational clinical studies have demonstrated that only 30–40 % of patients with arterial hypertension achieve the recommended blood pressure goals (below 140/90 mmHg). In contrast, interventional trials consistently showed that it is possible to achieve effective blood pressure targets in about 70 % of treated hypertensive patients with different cardiovascular risk profiles, especially through the use of rational, effective and well tolerated combination therapies. In order to bridge the gap between current and desired blood pressure control and to achieve more effective prevention of cardiovascular diseases, the Italian Society of Hypertension (SIIA) has developed an interventional strategy aimed at reaching nearly 70 % of treated controlled hypertensive patients by
2015. This ambitious goal can be realistically achieved by a more rational use of modern tools and supports, and also through the use of combination therapy in hypertension in daily clinical practice, especially if this approach can be simplified into a single pill (fixed combination therapy), which is a therapeutic option now also available in Italy. Since about 70–80 % of treated hypertensive patients require a combination therapy based on at least two classes of drugs in order to achieve the recommended blood pressure goals, it is of key importance to implement this strategy in routine clinical practice. Amongst the various combination therapies currently available for hypertension treatment and control, the use of those strategies based on drugs that antagonize the renin-angiotensin system, such as
M. Volpe (&) G. Tocci Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, Sant’Andrea Hospital, University of Rome ‘‘Sapienza’’, Via di Grottarossa 1035-39, 00189 Rome, Italy e-mail: [email protected]
N. De Luca Department of Clinical and Experimental Medicine, University of Napoli Federico II, Naples, Italy
E. A. Rosei Clinical Medicine, Department of Medical and Surgical Sciences, University of Brescia, Brescia, Italy E. Ambrosioni C. Borghi Chair of Internal Medicine, University of Bologna, Bologna, Italy S. Cottone Chair of Nephrology, Department of Internal Medicine and Specialties, University of Palermo, Palermo, Italy C. Cuspidi G. Mancia Department of Clinical Medicine and Prevention, Centr
Data Loading...